source
- Alkermes CEO targets orexin market after strong narcolepsy pill dataAlkermes' incoming chief executive outlined a strategy to compete with larger rivals in the emerging orexin drug class. Recent mid-June trial results showed the experimental oral compound alixorex…
- STAT readers split on spelling of "health care" as industry leans toward single wordSTAT recently asked its audience whether to write the term as two words or one. Roughly 60% of respondents favored one spelling over the other. The discussion highlights a subtle but growing trend…